REUMA INSTITUUT
ActiveSummary
REUMA INSTITUUT has been active since 1998 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €74,895 and a net result of -€704. Equity grew by about 7.6% per year on average since 2018. In 2025 it fell by 0.9%. Its solvency ranks better than 21% of 20,736 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 23-09-1998 Normal situation
- Activity
- Specialist medical practice NACE 86220and 2 others
- Joint committee
- 330 Health institutions and services · annual accounts 2025
- Establishment unit
- 2.186.134.530 3500 Hasselt, since 19-01-2010
- Financial year end
- 31 December
- Peppol
- Reachable since 09-12-2025
Board and ownership
- Isabelle de WERGIFOSSEManaging director
- Jan LENAERTSManaging director
- Femke MEYNENDirector
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- €286,086
- ▲ 0.2%
- Turnover
- ≈ €440,000
- estimated
- Loss
- €704
- Equity
- €74,895
- ▼ 0.9%
- Total assets
- €341,723
- ▼ 7.1%
- Employees on 31-12-2025
- 5
- =
Score breakdownlowers riskSector: Human health activities (NACE 86)Size: total assets €341,723Liquidity: current ratio 2.82, cash €51,771Figures for financial year 2025 (filed on 24-06-2026)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 21% of them on solvency, 41% on liquidity, 12% on profitability and 34% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 31 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Reappointments: Jan LENAERTS, Christine LANGENAKEN and 2 othersLegal-form conversion: from coöperatieve vennootschap met beperkte aansprakelijkheid to private limited company
- · Gazette deed 1 director appointed, 3 directors reappointedAppointment: Femke Meynen (director) · Reappointments: Christine Langenaken, Isabelle de Wergifosse and Jan Lenaerts
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as REUMA INSTITUUT: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €318,000 and €426,000, founded between 1997 and 2004.
| Company | Total assets | Gross margin |
|---|---|---|
| REUMA INSTITUUT Hasselt | €341,723 | €286,086 |
| DR. WAEBEN MARTINE Peer | €317,509 | €250,637 |
| DOKTER CHRISTEL LINSEN Lommel | €426,228 | €235,627 |
| CAPICARD Braine-le-Château | €331,034 | €311,609 |
| CABINET BALDASSARRE Nivelles | €324,166 | €245,948 |
| BASYL Nivelles | €426,042 | €279,685 |
| Cabinet Médical Anne Vanheesbeke Mons | €361,413 | €278,998 |
Key facts about REUMA INSTITUUT
- What is the company number of REUMA INSTITUUT?
- The company number of REUMA INSTITUUT is 0464.228.043. The VAT number is the same number with BE in front: BE 0464.228.043.
- Where is REUMA INSTITUUT based?
- The registered office is at Anne Frankplein 17, 3500 Hasselt.Company details
- What does REUMA INSTITUUT do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of REUMA INSTITUUT?
- REUMA INSTITUUT is a private limited company (BV).
- When was REUMA INSTITUUT founded?
- REUMA INSTITUUT was founded on 23-09-1998.
- Is REUMA INSTITUUT still active?
- Yes, REUMA INSTITUUT is an active enterprise in the KBO register.
- How many employees does REUMA INSTITUUT have?
- REUMA INSTITUUT had an average of 5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does REUMA INSTITUUT fall under?
- In its 2025 annual accounts, REUMA INSTITUUT states joint committee 330 (Health institutions and services).
- What is the turnover of REUMA INSTITUUT?
- The turnover in financial year 2025 is ≈ €440,000. This figure is estimated from the gross margin of €286,086 and 36 comparable companies (NACE 862). It probably lies between €400,000 and €550,000.
- Is REUMA INSTITUUT profitable?
- In financial year 2025, REUMA INSTITUUT made a loss of €704.
- Where can I find the annual accounts of REUMA INSTITUUT?
- REUMA INSTITUUT filed 27 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of REUMA INSTITUUT due?
- REUMA INSTITUUT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.